Share this article
Share this article
ResearchAndMarkets.com's offering.
The "Digital Solutions for Biomarkers Market: Industry Trends and Global Forecasts, 2021-2030" report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of digital solutions for biomarkers (either commercialized or under development) in the healthcare industry, over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
In the current pandemic scenario, medical professionals are trying to identify digital biomarkers that can facilitate the successful screening/diagnosis of COVID-19 patients, remotely. For instance, the National Institutes of Health (NIH) has tasked physIQ with developing and validating an algorithm, which can use existing wearable biosensor-derived analytics (generated by the company's pinpointIQT cloud platform) to discover a novel digital biomarker for COVID-19 associated decompensation.